Navigation Links
Watson Announces Preliminary Financial Performance for FY 2010
Date:1/12/2011

ref="http://www.videonewswire.com/event.asp?id=75026">http://www.videonewswire.com/event.asp?id=75026.  A replay of the webcast will also be available on Watson's web site.About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company. The Company is engaged in the development and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on urology and women's health. Watson has operations in many of the world's established and growing international markets.

In the U.S., the Watson brand portfolio includes RAPAFLO®, GELNIQUE®, Oxytrol®, TRELSTAR®, Crinone®  and INFeD®, and ella®.  In addition, Watson markets the following brands under co-promotion agreements: AndroGel®, with Abbott Laboratories, and Femring®, with Warner Chilcott plc. The Watson brand pipeline portfolio includes a number of products, including Prochieve®, under development with Columbia Laboratories for prevention of pre-term birth in women with a short cervix, recombinant follicle stimulating hormone (rFSH) in development with Itero Biopharmaceuticals for female infertility, EsmyaTM under development with Gedeon Richter for the treatment of uterine fibroids, and two novel new contraceptives.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Cautionary Statement Regarding Preliminary Results and Forward-Looking InformationStatements in this press release that refer to financial results for 2010, including earnings per share, are preliminary estimates and reflect Watson's expected financial results as of the date of this release, and are subject to change.  Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existin
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Watson to Host Investor Day on January 21 in New York City
2. Watsons Generic Fentora® Receives FDA Approval
3. Watson to Present at the 29th Annual JP Morgan Healthcare Conference
4. Watson Announces Novel Oral Contraceptive Approval
5. Watson and Richter Announce Exclusive License Agreement for Esmya™
6. Watson Confirms Exalgo™ Patent Challenge
7. Watson Announces Pricing of Secondary Offering By Selling Stockholder
8. Watson Announces Commencement of Secondary Offering by Selling Stockholder
9. Watson To Present At The 2010 Credit Suisse Healthcare Conference
10. Watson Confirms Crestor® Patent Challenge
11. Watsons Generic Version of Lotrel ® Receives FDA Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just ... "Quite a few doctors said he had a good chance ... Gionfriddo , about her now 20-month-old son, Kaiba. "At ... would take it and run with it." They ...
(Date:5/23/2013)... , May 23, 2013  Spring Bank Pharmaceuticals, Inc., ... of viral infections, today announced that it has initiated ... its investigational, once daily, oral therapy for the treatment ... HCV-infected patients and is designed to assess both the ... is a first-in-class drug for the treatment of chronic ...
(Date:5/23/2013)... ALBUQUERQUE, N.M. , May 23, 2013  Net ... in the telemedicine market, announced today the company has ... a telemedicine staffing company based in Huntsville, ... agency that specializes in the staffing and recruitment of ... upon completion of the final agreement, which is expected ...
Breaking Medicine Technology:Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3
... Dune Medical Devices, Inc. today announced that the ... for filing the company,s Pre-Market Approval (PMA) application ... that the PMA application was sufficiently complete and ... MarginProbe represents a breakthrough technology that may offer ...
... WASHINGTON, May 16, 2011 During Older ... encourages America,s seniors to connect with their pharmacist to ... and available wellness opportunities. As the most accessible health ... to discuss many of the issues that arise due ...
Cached Medicine Technology:FDA Formally Accepts Dune Medical's MarginProbe™ System Pre-Market Approval (PMA) Application and Grants Expedited Review Status 2APhA Encourages Seniors to Connect with Their Pharmacist to Increase Wellness and Medication Knowledge 2APhA Encourages Seniors to Connect with Their Pharmacist to Increase Wellness and Medication Knowledge 3
(Date:5/23/2013)... May 23, 2013 Today, Zane Benefits, ... mandate . Zane Benefits, which provides comprehensive and flexible ... leader in defined contribution plans and ... a common question from employees is “does my employer ... website, not necessarily. The health care reform law, called ...
(Date:5/23/2013)... Mann HealthDay Reporter , , THURSDAY, May 23 ... take to help treat hip and knee osteoarthritis may ... for developing glaucoma, a small new study of older ... an increase of intraocular pressure (IOP) or pressure inside ... leading causes of blindness. In the ...
(Date:5/23/2013)... journal Science published an article about bexarotene ... an important starting point for further Alzheimer,s research. The ... at VIB and KU Leuven in collaboration with ... and scientists at Janssen Pharmaceutica, Beerse, also tested this ... results were different, as were those of two American ...
(Date:5/23/2013)... about to be tested in a clinical trial by ... for Alzheimer,s disease has failed to work with the ... according to results of a study by University of ... neuroscience affiliated with the Evelyn F. and William L. ... the importance of verifying promising research results before investing ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Dr. ... her new charitable organization in Orange County, OCCares , ... in Orange County. The event details are as follows: ... Orangewood Academy Auditorium, 13732 Clinton Street, Garden Grove, CA 92843 ... pop crossover music by Christian vocalists Charmaine & Jonathan Thulin. ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on the Employer Mandate 2Health News:Zane Benefits Publishes New Information on the Employer Mandate 3Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:New insights contradict promising Alzheimer's research 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 2Health News:Dr. Katherine Ahn is Proud to Announce the Launch Her Family's New Charity OCCares 3
... was more rapid afterward, study finds , , TUESDAY, Oct. ... education seems to delay the onset of dementia, but ... a new study finds. , The findings confirm ... with more education have some kind of brain "reserve" ...
... dont dispute the important role that diet and activity ... eating habits and a less active lifestyle fully explain ... That question has led some researchers to ask whether ... In the October issue of Mayo Clinic Proceedings, researcher ...
... calls for greater collaboration across Europe on research in ... in improved and cost-effective healthcare, the ESF says, but ... and industry if Europe is to realise the full ... The call comes in a new ESF Science Policy ...
... LA JOLLA, Calif., Oct. 23 Immunosyn,Corporation (OTC Bulletin ... as the company,s Chief Executive Officer, President and,board member. ... role at Immunosyn and help,shape the company,s success. I ... life for millions of people who suffer from painful ...
... of fatigue might find some relief through regular exercise ... a new review. , Fatigue is one of ... those undergoing treatment with radiation and chemotherapy. According to ... cancer treatment experience fatigue that can range from mild ...
... McKusick-Nathans Institute of Genetic Medicine today are releasing newly ... Hopkins data, coordinated with a similar data release from ... hereditary factors and speed the understanding of autism by ... look to date at the genetic variation patterns in ...
Cached Medicine News:Health News:Dementia in More Educated Hits Later But Harder 2Health News:Mayo Clinic Proceedings article explores possible link between obesity and viral infections 2Health News:Mayo Clinic Proceedings article explores possible link between obesity and viral infections 3Health News:Improving Europe's image 2Health News:Immunosyn Corporation Names Stephen Ferrone as CEO 2Health News:Exercise and psychological counseling could ease cancer-related fatigue 2Health News:Exercise and psychological counseling could ease cancer-related fatigue 3Health News:Hopkins researchers release genome data on autism 2
... Hold & Support A Dropping Lens To Safely ... Phacoemulsification To ,Continue. Can Support Multiple ... Cyclodialysis Spatula To Reach Into The ... Lens Fragments With One Instrument. ,A 23g ...
... In-Line Footplates Are Turned 90 Degrees ... Diamond Blade While Incising Tissue. ,Special Mirror-Polished ... Depth Penetration.,Pre-Set Blade Extension Settings Of ... And Full Extension.,1mm Wide Snub Nose ...
... 0.1mm Pierce Tip Opening Is Designed ... The Need For A Separate Cystotome. The 11mm ... Without Elevating The Incision.,The Distal Jaws Have Platforms, ... To Prevent Inadvertent Pick Up Of Iris. The ...
2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
Medicine Products: